Complete remission of Hodgkin’s lymphoma in a pediatric patient with TTN gene mutation treated with brentuximab vedotin combined chemotherapy without anthracyclines: A case report

INTRODUCTION: There is no guideline for the treatment of Hodgkin’s lymphoma (HL) in pediatric patients with titin (TTN) gene mutation and heart failure. We explored the feasibility of using brentuximab vedotin (BV) plus chemotherapy without anthracyclines to treat one pediatric HL patient with TTN m...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Liu, Ligang, Sun, Hao, Li, Nan, Huang, Shuang, Olinger, Alexander, Xu, Xiaolin, Wang, Xiaoling, Duan, Yanlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618631/
https://www.ncbi.nlm.nih.gov/pubmed/36324585
http://dx.doi.org/10.3389/fonc.2022.1006166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618631/
https://www.ncbi.nlm.nih.gov/pubmed/36324585
http://dx.doi.org/10.3389/fonc.2022.1006166

Ejemplares similares